One of the things I enjoy most about interviewing longtime investors is hearing them challenge assumptions that many people have come to accept as fact. That happened repeatedly in my conversation ...

Several prominent biotech-focused hedge funds are backing Talawar Therapeutics' merger with JATT II Acquisition, a special purpose acquisition company that found a merger partner just over two months ...

Six years ago, Donna Snider built Hackensack Meridian Health's investment office from scratch just as the Covid pandemic began. Now, the New Jersey-based healthcare system’s first dedicated investment ...

Asset managers aren’t investing as aggressively in artificial intelligence as the hype might suggest. Despite the talk surrounding AI’s ubiquity and inevitability, new research from the Thinking Ahead ...

Last week, Institutional Investor announced finalists in five categories of our annual Allocators’ Choice Awards. Now it's time to learn who is in the running for Corporate Pension Plan CIO of the ...

The Doris Duke Foundation’s long biotechnology bet is paying off after a five-year winter. The $2.2 billion portfolio has steadily expanded its exposure to health and life sciences as part of a ...

Daniel Michalow was a golden child at D.E. Shaw, the now-$70 billion hedge fund he joined in 2004 at the age of 21, straight out of Harvard. By the end of 2011, he had become the firm’s youngest ...

The big managers continue to get bigger through M&A, with MetLife’s institutional asset management business buying PineBridge Investments this week. MetLife Investment Management is purchasing ...

The Heinz Endowments, a decades-old foundation created by the family that started the H. J. Heinz Company, best known for its ketchup, is suing a former employee for embezzling almost $1 million of ...

After graduating in 1994 from the United States Naval Academy, one of the top colleges in the country, Matt Gibson returned the favor like most midshipmen by serving in the Navy for five years. He ...